Spectral analysis of blood pressure and heart rate, catecholamine and neuropeptide Y plasma levels in a new model of neurogenic orthostatic hypotension in dog

Clinical Autonomic Research

Volumn 6, Issue 2, 1996, Pages 75-82

  Verwaerde, P ^a   Senard, J M ^a   Mazerolles, M ^a   Tran, M A ^a   Damase Michel, C ^a   Montastruc, J L ^a   Montastruc, P ^a  

^a INSERM   (France)

Author keywords

Catecholamines; Neuropeptide Y; Orthostatic hypotension; Sine aortic denervation; Spectral analysis; Tilt test

Indexed keywords

CATECHOLAMINE DERIVATIVE; NEUROPEPTIDE Y; NORADRENALIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DENERVATION; HEART RATE; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; ORTHOSTATIC HYPOTENSION; SPECTROSCOPY; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE;

EID: 0029944167     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02291227     Document Type: Article

References (38)

1. Rutan GH, Hermanson B, Bild DE, Kittner SJ, La Baw F, Tell GS. Orthostatic hypotension in older adults. The cardiovascular health study. Hypertension 1992; 19: 508-519.
2. Ensrud KE, Nevitt NC, Yunis C, Hulley SB, Grimm RH, Cummings SR. Postural hypotension and postural dizziness in elderly women. The study of osteoporotic fractures. Arch Intern Med 1992; 152: 1058-1064.
3. Schatz IJ. Orthostatic Hypotension. Philadelphia: F.A. Davis Company, 1986 .
4. Mathias CJ, Bannister R. Investigation of autonomic disorders. In: Bannister R. and Mathias CJ, eds. Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System, 3rd edn. Oxford: Oxford University Press, 1992; pp: 255-290.
5. Ahmad RAS, Watson RDS. Treatment of postural hypotension: a review. Drugs 1990; 39: 74-85.
6. Lee CH, Stosberg AM, Roszkowski AP, Warren LA. A model for evaluation of postural hypotension induced by drugs in conscious restrained normotensive rats. J Pharmacol Methods 1982; 7: 15-24.
7. 1A receptor agonists. J Pharmacol Exp Ther 1991; 259: 1221-1230.
8. Pourrias B, Marie C. Effects of tilting in the anaesthetized and mechanically ventilated rat: a model of orthostatic hypotension. Fundam Clin Pharmacol 1992; 6: 37-44.
9. 2-adrenoceptor blockade in chronic prazosin-pretreated conscious spontaneously hypertensive rats. J Auton Pharmacol 1992; 12: 191-204.
10. Yamazaki R, Tsuchida K, Aihara H. Effects of midodrine on experimentally-induced postural hypotension and venous pooling in dogs. J Pharmacol Exp Ther 1987; 237: 86-91.
11. 2-adrenergic supersensitivity and platelet α-adrenoceptor up-regulation in dog. Br J Pharmacol 1990; 101: 329-336.
12. Valet P, Damase-Michel C, Montastruc JL, Montastruc P. Plasma catecholamines and adrenoceptors after chronic sinoaortic denervation in dogs. Fundam Clin Pharmacol 1989; 3: 307-320.
13. Poncet MF, Damase-Michel C, Tavernier G et al. Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs. Br J Pharmacol 1992; 105: 181-183.
14. Baum T, Sabin C, Moran RM. Comparison of hypotensive orthostatic and sympathetic inhibitory action of antihypertensive drugs in rats. Clin Exp Hypertens 1981; 3: 219-243.
15. Humphrey SJ, McCall RB. A rat model for predicting orthostatic hypotension during acute and chronic antihypertensive drug therapy. J Pharmacol Methods 1982; 7: 25-34.
16. Lee JY, Brune ME, Warner RB, Debernardis JF. Orthostatic hypotension occurs following α-adrenoceptor blockade in chronic prazosin-pretreated conscious spontaneously hypertensive rats. J. Auton Pharmacol 1992; 12: 191-204.
17. Senard JM, Rascol O, Durrieu G et al. Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson's disease or multiple system atrophy. Clin Neuropharmacol 1993; 16: 70-76.
18. Galinier M, Senard JM, Valet P et al. Myocardial hypertrophy, cardiac ß-adrenoceptors and adenylate cyclase activity during sinoaortic denervation in dogs. Br J Pharmacol 1992; 105: 341-346.
19. Orfila C, Damase-Michel C, Lepert JC et al. Renal morphological changes after sinoaortic denervation in dogs. Hypertension 1993; 21: 758-766.
20. Cohen J, Low P, Fealey R, Sheps S, Jiang NS. Somatic and autonomic function in progressive autonomic failure and multiple system atrophy. Ann Neurol 1987; 22: 692-699.
21. Pagani M, Lombardi F, Guzzetti S et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986; 59: 178-193.
22. Akselrod S. Spectral analysis of fluctuations in cardiovascular parameters: a quantitative tool for the investigation of autonomic control. Trends Pharmacol Sci 1988; 9: 6-9.
23. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuations: a quantitative probe of beat-to-beat cardiovascular control. Science 1981; 59: 178-193.
24. Hedman AE, Hartikaienen JEK, Tahvanainen KUO, Hakamäki MOK. Power spectral analysis of heart rate and blood pressure variability in anaesthetized dogs. Acta Physiol Scand 1992; 146: 155-164.
25. Behnia R, Koushanpour E. Local versus central effect of halothane on carotid sino baroreceptor function. Anesthesiology 1984; 61: 161-164.
26. Bernards C, Marrone B, Priano L. Effect of anesthetic induction on baroreceptor function. Anesthesiology 1985, 63: A31.
27. Persson PB, Stauss H, Chung O, Wittmann U, Unger T. Spectrum analysis of sympathetic nerve activity and blood pressure in conscious rats. Am J Physiol 1992; 263: H1348-H1355.
28. Guzzetti S, Piccaluga E, Casati R. Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. J Hypertens 1988; 6: 711-717.
29. Japundzic N, Grichois ML, Zitoun P, Laude D, Elghozi JL. Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers. J Autonom Nerv Syst 1990; 30: 91-100.
30. Cerutti C, Gustin MP, Paultre CZ et al. Autonomic nervous system and cardiovascular variability in rats: a spectral analysis approach. Am J Physiol 1991; 261: H1292-H1299.
31. Covert RF, Schreiber MD, Torgerson LJ. Effect of beta-adrenergic antagonism on chloralose-induced hemodynamic changes in newborn lambs. J Cardiovasc Pharmacol 1992; 20: 990-996.
32. Frankel RA, Metting PJ, Britton SL. Evaluation of spontaneous baroreflex sensitivity in conscious dogs. J Physiol 1993; 462: 31-45.
33. Persson PB, Ehmke H, Kohler W, Kircheim H. Identification of major slow blood pressure oscillations in conscious dogs Am J Physiol 1990; 25: H1050-H1055.
34. Barres C, Cerutti C, Paultre CZ, Sassard J. Antihypertensive effects of S9490-3, a new converting enzyme inhibitor, in the conscious spontaneously hypertensive rat. Clin Sci 1986; 70: 167-175.
35. Dutrey-Dupagne C, Girard A, Ulmann A, Elghozi JL. Effect of the converting enzyme inhibitor trandolapril on short-term variability of blood pressure in essential hypertension. Clin Auton Res 1991; 1: 303-307.
36. Butler GC, Yamamoto Y, Hughson RL. Heart rate variability to monitor autonomic nervous system activity during orthostatic stress. J Clin Pharmacol 1994; 34: 558-562.
37. Pernow J, Lundberg JM, Kaijser L et al. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol 1986; 6: 561-578.
38. Tavernier G, Damase-Michel C, Portolan G, Tran MA, Montastruc JL. Is neuropeptide Y co-released with catecholamines in experimental arterial hypertension following sinoaortic denervation? Naunyn-Schmiedeberg's Arch Pharmacol 1992; 345: 431-436.